f
1
{
f
1
{
            
2
  "author": "",
2
  "author": "",
            
3
  "author_email": "",
3
  "author_email": "",
            
4
  "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c",
4
  "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c",
            
5
  "groups": [],
5
  "groups": [],
            
6
  "id": "b29dd35e-fbfd-4f08-94ed-dfe0a222b911",
6
  "id": "b29dd35e-fbfd-4f08-94ed-dfe0a222b911",
            
7
  "isopen": false,
7
  "isopen": false,
            
8
  "license_id": "notspecified",
8
  "license_id": "notspecified",
            
9
  "license_title": "License not specified",
9
  "license_title": "License not specified",
            
10
  "maintainer": null,
10
  "maintainer": null,
            
11
  "maintainer_email": null,
11
  "maintainer_email": null,
            
12
  "metadata_created": "2023-07-13T19:57:26.642548",
12
  "metadata_created": "2023-07-13T19:57:26.642548",
            
n
13
  "metadata_modified": "2023-07-13T19:59:11.843728",
n
13
  "metadata_modified": "2023-07-13T20:00:28.503488",
            
14
  "name": "hiv-drug-resistance-testing-application-form-version2",
14
  "name": "hiv-drug-resistance-testing-application-form-version2",
            
15
  "notes": "* This form is used for requesting the National HIV drug 
15
  "notes": "* This form is used for requesting the National HIV drug 
            
16
resistance (HIVDR) Expert Committee Patients to review a patient with 
16
resistance (HIVDR) Expert Committee Patients to review a patient with 
            
17
confirmed viral failure for potential drug resistance testing. 
17
confirmed viral failure for potential drug resistance testing. 
            
18
Patients on DTG- and PI-based regimens who don\u2019t re-suppress 
18
Patients on DTG- and PI-based regimens who don\u2019t re-suppress 
            
19
below 1000 copies/ml after an initial high VL despite good adherence 
19
below 1000 copies/ml after an initial high VL despite good adherence 
            
20
need a genotype sample for resistance testing.\r\n* Contact the HIVDR 
20
need a genotype sample for resistance testing.\r\n* Contact the HIVDR 
            
21
Expert Committee, either through the Department of HIV, STI and Viral 
21
Expert Committee, either through the Department of HIV, STI and Viral 
            
22
Hepatitis, or by sending an email to 
22
Hepatitis, or by sending an email to 
            
23
3rdlineart@lighthouse.org.mw.\r\n* Follow the instructions on the 
23
3rdlineart@lighthouse.org.mw.\r\n* Follow the instructions on the 
            
24
application form and ensure that the application form is completely 
24
application form and ensure that the application form is completely 
            
25
filled before sending it to the expert committee.\r\n* The expert 
25
filled before sending it to the expert committee.\r\n* The expert 
            
26
committee will advise if a genotype sample needs to be collected. 
26
committee will advise if a genotype sample needs to be collected. 
            
27
Genotyping is only possible if the current VL is 1000+ and will be 
27
Genotyping is only possible if the current VL is 1000+ and will be 
            
28
more reliable from 5000+.\r\n* The genotype result can only be 
28
more reliable from 5000+.\r\n* The genotype result can only be 
            
29
interpreted correctly if the patient has been taking their ARVs 
29
interpreted correctly if the patient has been taking their ARVs 
            
30
consistently for 2-3 months before the sample was collected.\r\n* 
30
consistently for 2-3 months before the sample was collected.\r\n* 
            
31
Maintain the current regimen until genotyping results are 
31
Maintain the current regimen until genotyping results are 
            
32
available.\r\n* Follow the regimen recommendations from the National 
32
available.\r\n* Follow the regimen recommendations from the National 
            
33
HIVRDR expert committee.\r\n",
33
HIVRDR expert committee.\r\n",
            
34
  "num_resources": 1,
34
  "num_resources": 1,
            
35
  "num_tags": 4,
35
  "num_tags": 4,
            
36
  "organization": {
36
  "organization": {
            
37
    "approval_status": "approved",
37
    "approval_status": "approved",
            
38
    "created": "2021-10-14T11:02:35.234558",
38
    "created": "2021-10-14T11:02:35.234558",
            
39
    "description": "The Department of HIV & AIDS (DHA) was established 
39
    "description": "The Department of HIV & AIDS (DHA) was established 
            
40
in 2001, initially as a unit in the Department of Clinical Services, 
40
in 2001, initially as a unit in the Department of Clinical Services, 
            
41
to coordinate the biomedical HIV Program in Malawi. The department now 
41
to coordinate the biomedical HIV Program in Malawi. The department now 
            
42
carries responsibility for various HIV related programs including: 
42
carries responsibility for various HIV related programs including: 
            
43
sexually transmitted infections (STIs), prevention of mother to child 
43
sexually transmitted infections (STIs), prevention of mother to child 
            
44
transmission of HIV (PMTCT), and national voluntary male medical 
44
transmission of HIV (PMTCT), and national voluntary male medical 
            
45
circumcision program (VMMC). All these HIV program sub-sections are 
45
circumcision program (VMMC). All these HIV program sub-sections are 
            
46
linked to one robust monitoring and evaluation sub-section in the HIV 
46
linked to one robust monitoring and evaluation sub-section in the HIV 
            
47
and AIDS Department which technically operates under the Central 
47
and AIDS Department which technically operates under the Central 
            
48
Monitoring and Evaluation Department (CMED) of the Ministry of 
48
Monitoring and Evaluation Department (CMED) of the Ministry of 
            
49
Health.",
49
Health.",
            
50
    "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b",
50
    "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b",
            
51
    "image_url": 
51
    "image_url": 
            
52
2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg",
52
2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg",
            
53
    "is_organization": true,
53
    "is_organization": true,
            
54
    "name": "dha",
54
    "name": "dha",
            
55
    "state": "active",
55
    "state": "active",
            
56
    "title": "Department of HIV & AIDS and Viral Hepatitis",
56
    "title": "Department of HIV & AIDS and Viral Hepatitis",
            
57
    "type": "organization"
57
    "type": "organization"
            
58
  },
58
  },
            
59
  "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b",
59
  "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b",
            
60
  "private": false,
60
  "private": false,
            
61
  "program_area": "Care and Treatment",
61
  "program_area": "Care and Treatment",
            
62
  "relationships_as_object": [],
62
  "relationships_as_object": [],
            
63
  "relationships_as_subject": [],
63
  "relationships_as_subject": [],
            
64
  "resources": [
64
  "resources": [
            
65
    {
65
    {
            
66
      "cache_last_updated": null,
66
      "cache_last_updated": null,
            
67
      "cache_url": null,
67
      "cache_url": null,
            
68
      "created": "2023-07-13T19:59:09.463717",
68
      "created": "2023-07-13T19:59:09.463717",
            
69
      "description": "",
69
      "description": "",
            
70
      "format": "PDF",
70
      "format": "PDF",
            
71
      "hash": "",
71
      "hash": "",
            
72
      "id": "fb33adaa-95f9-42d1-b418-51db261e1449",
72
      "id": "fb33adaa-95f9-42d1-b418-51db261e1449",
            
73
      "last_modified": "2023-07-13T19:59:09.428725",
73
      "last_modified": "2023-07-13T19:59:09.428725",
            
74
      "lfs_prefix": 
74
      "lfs_prefix": 
            
75
"dha/hiv-drug-resistance-testing-application-form-version2",
75
"dha/hiv-drug-resistance-testing-application-form-version2",
            
76
      "metadata_modified": "2023-07-13T19:59:11.848180",
76
      "metadata_modified": "2023-07-13T19:59:11.848180",
            
77
      "mimetype": "application/pdf",
77
      "mimetype": "application/pdf",
            
78
      "mimetype_inner": null,
78
      "mimetype_inner": null,
            
79
      "name": "HIV drug resistance testing application form (version2, 
79
      "name": "HIV drug resistance testing application form (version2, 
            
80
2022)",
80
2022)",
            
81
      "package_id": "b29dd35e-fbfd-4f08-94ed-dfe0a222b911",
81
      "package_id": "b29dd35e-fbfd-4f08-94ed-dfe0a222b911",
            
82
      "position": 0,
82
      "position": 0,
            
83
      "resource_type": null,
83
      "resource_type": null,
            
84
      "sha256": 
84
      "sha256": 
            
85
"2a98494d7cf6adc55657e8069018e3090bea10eb232dafe0f36bff53879d8071",
85
"2a98494d7cf6adc55657e8069018e3090bea10eb232dafe0f36bff53879d8071",
            
86
      "size": 173904,
86
      "size": 173904,
            
87
      "state": "active",
87
      "state": "active",
            
88
      "url": 
88
      "url": 
            
89
nload/hiv-drug-resistance-testing-application-form-version2-2022.pdf",
89
nload/hiv-drug-resistance-testing-application-form-version2-2022.pdf",
            
90
      "url_type": "upload"
90
      "url_type": "upload"
            
91
    }
91
    }
            
92
  ],
92
  ],
            
93
  "state": "active",
93
  "state": "active",
            
94
  "tags": [
94
  "tags": [
            
95
    {
95
    {
            
96
      "display_name": "application form",
96
      "display_name": "application form",
            
97
      "id": "d1616958-4f82-48ca-aeb2-99ef30e5e620",
97
      "id": "d1616958-4f82-48ca-aeb2-99ef30e5e620",
            
98
      "name": "application form",
98
      "name": "application form",
            
99
      "state": "active",
99
      "state": "active",
            
100
      "vocabulary_id": null
100
      "vocabulary_id": null
            
101
    },
101
    },
            
102
    {
102
    {
            
103
      "display_name": "drug resistance",
103
      "display_name": "drug resistance",
            
104
      "id": "d11f3810-676d-4e35-811e-e0df464c2a96",
104
      "id": "d11f3810-676d-4e35-811e-e0df464c2a96",
            
105
      "name": "drug resistance",
105
      "name": "drug resistance",
            
106
      "state": "active",
106
      "state": "active",
            
107
      "vocabulary_id": null
107
      "vocabulary_id": null
            
108
    },
108
    },
            
109
    {
109
    {
            
110
      "display_name": "hiv",
110
      "display_name": "hiv",
            
111
      "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404",
111
      "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404",
            
112
      "name": "hiv",
112
      "name": "hiv",
            
113
      "state": "active",
113
      "state": "active",
            
114
      "vocabulary_id": null
114
      "vocabulary_id": null
            
115
    },
115
    },
            
116
    {
116
    {
            
117
      "display_name": "testing",
117
      "display_name": "testing",
            
118
      "id": "eadc59f0-fcde-422f-9aa2-2a863c0c6749",
118
      "id": "eadc59f0-fcde-422f-9aa2-2a863c0c6749",
            
119
      "name": "testing",
119
      "name": "testing",
            
120
      "state": "active",
120
      "state": "active",
            
121
      "vocabulary_id": null
121
      "vocabulary_id": null
            
122
    }
122
    }
            
123
  ],
123
  ],
            
t
124
  "title": "HIV drug resistance testing application form version 2",
t
124
  "title": "HIV drug resistance testing application form (version2, 
            
125
2022)",
            
125
  "type": "dataset",
126
  "type": "dataset",
            
126
  "url": null,
127
  "url": null,
            
127
  "version": null,
128
  "version": null,
            
128
  "year": "2022"
129
  "year": "2022"
            
129
}
130
}